Abstract
Cold atmospheric plasma (CAP) sources are attractive sources of reactive species with promising industrial and biomedical applications, but an understanding of underlying surface mechanisms is lacking. A kHz-powered surface microdischarge (SMD) operating with N2/O2 mixtures was used to study the biological deactivation of two immune-stimulating biomolecules: lipopolysaccharide (LPS) and peptidoglycan (PGN), found in bacteria such as Escherichia coli and Staphylococcus aureus, respectively. Model polymers were also studied to isolate specific functional groups. Changes in the surface chemistry were measured to understand which plasma-generated species and surface modifications are important for biological deactivation. The overall goal of this work is to determine which effects of CAP treatment are generic and which bonds are susceptible to attack. CAP treatment deactivated biomolecules, oxidized surfaces, and introduced surface bound NO3. These effects can be controlled by the N2 fraction in O2 and applied voltage and vary among different target surfaces. The SMD was compared with an Ar/O2/N2-fed kHz-powered atmospheric pressure plasma jet and showed much higher surface modifications and surface chemistry tunability compared to the jet. Possible mechanisms are discussed and findings are compared with recent computational investigations. Our results demonstrate the importance of long-lived plasma-generated species and advance an atomistic understanding of CAP-surface interactions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.